Zentiva, a leading European generics pharmaceutical company, Advent and GTCR – two leading global private equity investors – today announce the sale of Zentiva by Advent to GTCR.
At Zentiva, we provide health and wellbeing for all generations
News from Zentiva
-
September 11, 2025 / News
-
May 21, 2025 / News
Zentiva supported Euractiv’s Health Policy Conference in Brussels, where its CEO, Steffen Saltofte, joined senior EU policymakers in the opening panel titled “The EU Pharmaceutical Legislation – Ensuring Fair Access to Medicines for All.”
-
April 9, 2025 / News
For the fourth consecutive year, Zentiva is publishing its Sustainability Report, highlighting the key achievements delivered in 2024.
-
September 11, 2025 / News
Zentiva, a leading European generics pharmaceutical company, Advent and GTCR – two leading global private equity investors – today announce the sale of Zentiva by Advent to GTCR.
-
May 21, 2025 / News
Zentiva supported Euractiv’s Health Policy Conference in Brussels, where its CEO, Steffen Saltofte, joined senior EU policymakers in the opening panel titled “The EU Pharmaceutical Legislation – Ensuring Fair Access to Medicines for All.”
-
April 9, 2025 / News
For the fourth consecutive year, Zentiva is publishing its Sustainability Report, highlighting the key achievements delivered in 2024.
-
March 19, 2020 / Featured
During this pandemic crisis, Zentiva has two main responsibilities: continue to supply the medicines people depend on every day and protect and guarantee the safety of our employees.
